Literature DB >> 3311856

Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes.

J P Felber1, E Ferrannini, A Golay, H U Meyer, D Theibaud, B Curchod, E Maeder, E Jequier, R A DeFronzo.   

Abstract

Increased lipid oxidation is generally observed in subjects with obesity and diabetes and has been suggested to be responsible for the insulin resistance associated with these conditions. We measured, by continuous indirect calorimetry, lipid and glucose oxidation and nonoxidative glucose disposal in 82 obese subjects during a 100-g oral glucose tolerance test (OGTT) and in 26 during a euglycemic insulin (40 mU.min-1.m-2) clamp. The obese subjects were subdivided into those with normal glucose tolerance (group A), those with impaired glucose tolerance (group B), and those with overt diabetes (group C). Forty-five healthy nonobese subjects were subdivided into a young and an older control group, which were age-matched to the nondiabetic obese (groups A and B) and diabetic obese (group C) subjects, respectively. In the postabsorptive state, as well as in response to insulin stimulation (both OGTT and insulin clamp), lipid oxidation was significantly increased in all three obese groups in comparison with either young or older controls. Basal glucose oxidation was significantly decreased in obese nondiabetic and obese glucose--intolerant subjects (groups A and B) compared with age-matched controls. During the OGTT and during the insulin clamp, insulin-stimulated glucose oxidation was decreased in all three obese groups. In contrast, nonoxidative glucose disposal was markedly inhibited in nondiabetic and diabetic obese patients during the euglycemic insulin clamp but not during the OGTT. After glucose ingestion, nonoxidative glucose uptake was normal in nondiabetic obese and glucose-intolerant obese subjects and decreased in diabetic obese subjects. Statistical analysis revealed that lipid and glucose oxidation were strongly and inversely related in the basal state, during euglycemic insulin clamp, and during OGTT. The negative correlation between lipid oxidation and nonoxidative glucose uptake, although significant, was much weaker. Fasting and post-OGTT hyperglycemia were the strongest (negative) correlates of nonoxidative glucose disposal in both single and multiple regression models. We conclude that 1) reduced glucose oxidation and reduced nonoxidative glucose disposal partake of the insulin resistance of nondiabetic obese and diabetic obese individuals; 2) hyperglycemia provides a compensatory mechanism for the defect in nonoxidative glucose disposal in nondiabetic obese subjects; however, this compensation is characteristically lost when overt diabetes ensues; and 3) increased lipid oxidation may contribute, in part, to the defects in glucose oxidation and nonoxidative glucose uptake in obesity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3311856     DOI: 10.2337/diab.36.11.1341

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  58 in total

1.  A case of congenital generalized lipodystrophy: metabolic effects of four dietary regimens. Lack of association of CGL with polymorphism in the lamin A/C Gene.

Authors:  R Kazlauskaite; A T Santomauro; J Goldman; K Silver; S Snitker; B A Beamer; C J Yen; A R Shuldiner; B L Wajchenberg
Journal:  Clin Endocrinol (Oxf)       Date:  2001-03       Impact factor: 3.478

2.  Effect of long-term strength training on glucose metabolism. Implications for individual impact of high lean mass and high fat mass on relationship between BMI and insulin sensitivity.

Authors:  A Gippini; A Mato; R Pazos; B Suarez; B Vila; P Gayoso; M Lage; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

Review 3.  Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview.

Authors:  R A DeFronzo
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

4.  Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects.

Authors:  R Coccurello; A Caprioli; O Ghirardi; R Conti; B Ciani; S Daniele; A Bartolomucci; A Moles
Journal:  Psychopharmacology (Berl)       Date:  2006-05-13       Impact factor: 4.530

5.  The effect of insulin on the intracellular distribution of 14(R,S)-[18F]Fluoro-6-thia-heptadecanoic acid in rats.

Authors:  Xiuli Ci; Frédérique Frisch; François Lavoie; Pascale Germain; Roger Lecomte; Johan E van Lier; François Bénard; André C Carpentier
Journal:  Mol Imaging Biol       Date:  2006 Jul-Aug       Impact factor: 3.488

6.  Novel noninvasive breath test method for screening individuals at risk for diabetes.

Authors:  E Lichar Dillon; Morteza Janghorbani; James A Angel; Shanon L Casperson; James J Grady; Randall J Urban; Elena Volpi; Melinda Sheffield-Moore
Journal:  Diabetes Care       Date:  2008-12-15       Impact factor: 19.112

Review 7.  Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus?

Authors:  Bret H Goodpaster; David E Kelley
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

8.  Skeletal muscle utilization of free fatty acids in women with visceral obesity.

Authors:  S R Colberg; J A Simoneau; F L Thaete; D E Kelley
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

9.  Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus.

Authors:  A Vaag; J E Henriksen; H Beck-Nielsen
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

10.  Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.

Authors:  L C Groop; R C Bonadonna; S DelPrato; K Ratheiser; K Zyck; E Ferrannini; R A DeFronzo
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.